Skip Navigation

This Article
Right arrow Print PDF (5817K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Romig, H.
Right arrow Articles by Richter, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romig, H.
Right arrow Articles by Richter, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1990, Vol. 18, No. 4 801-808
© 1990

MOLECULAR BIOLOGY

Expression of the type I DNA topoisomerase gene in adenovirus-5 infected human cells

Helmut Romig and Arndt Richter*

Universität Konstariz, Fakuität für Biologie D-7750 Konstanz, FRG

*To whom correspondence should be addressed

Received November 14, 1989. Revised January 17, 1990. Accepted January 17, 1990.

The amount of topoisomerase I specific mRNA increases three- to fivefold during the early phase of infection of HeLa cells with adenovirus-5. The observed increase in specific mRNA is mainly due to an Increased rate of transcription of the gene. In human 293 cells, which constitutiveiy express the viral E1A and E1B genes, we determined an elevated level of topoisomerase I mRNA, comparable to the amount of mRNA present in HeLa cells early after infection with adenovirus. in contrats, in HeLa cells Infected with adenovirus d1312, a mutant were the E1A region had been deleted, the amount of topoisomerase I mRNA remained constant, unless the cells we superinfected with wild type virus. Our experiments indicate that the topolsomerase I gene is transactlvated by an early adenovirus protein product coded by the E1A region. in contrast to the increase In mRNA synthesis, the amount of topolsomerase I protein and the topoismerase I activity remain constant up to 24 hours after infection.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
C. Gomez-Manzano, M. M. Alonso, W.K. A. Yung, F. McCormick, D. T. Curiel, F. F. Lang, H. Jiang, B. N. Bekele, X. Zhou, R. Alemany, et al.
Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan
Clin. Cancer Res., January 15, 2006; 12(2): 556 - 562.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. Gomez-Manzano, W.K. A. Yung, R. Alemany, and J. Fueyo
Genetically modified adenoviruses against gliomas: From bench to bedside
Neurology, August 10, 2004; 63(3): 418 - 426.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
U. Vanhoefer, A. Harstrick, W. Achterrath, S. Cao, S. Seeber, and Y. M. Rustum
Irinotecan in the Treatment of Colorectal Cancer: Clinical Overview
J. Clin. Oncol., March 1, 2001; 19(5): 1501 - 1518.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. Wildner, R. M. Blaese, and J. C. Morris
Therapy of Colon Cancer with Oncolytic Adenovirus Is Enhanced by the Addition of Herpes Simplex Virus-thymidine kinase
Cancer Res., January 1, 1999; 59(2): 410 - 413.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.